InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by BAUM CHARLES M, Chairman & CEO. Insider active across 2 companies, notably Mirati Therapeutics, Inc.. Cumulatively, 23 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €1.2m. Activity tracked since 18 June 2021. The latest transaction was disclosed on 17 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations23 total
78,600 sharesCommon StockSEC:0001415889-25-001085:0
19,650 shares0Common StockSEC:0000950170-24-074864:0
123,389 sharesCommon StockSEC:0001140361-24-003528:0
94,057 sharesCommon StockSEC:0001140361-24-003528:1
20,425 sharesCommon StockSEC:0001140361-24-003528:2
20,425 shares@ US$58.7516.5% of flowCommon StockSEC:0001628280-24-000277:0
54,054 shares@ US$37.0027.7% of flowCommon StockSEC:0001628280-23-028884:0
19,650 shares0Common StockSEC:0000950170-23-028605:0
4,444 shares0Common StockSEC:0001214659-23-001049:0
3,648 shares@ US$46.602.5% of flowCommon StockSEC:0001214659-23-000290:0
53,618 shares0Common StockSEC:0001214659-22-015200:0
69,256 shares@ US$17.4117.7% of flowCommon StockSEC:0001214659-22-014229:0
39,300 shares0Common StockSEC:0001209191-22-037669:0
25,543 shares0Common StockSEC:0001214659-22-000856:0
25,543 shares0Common StockSEC:0001214659-22-000856
4,045 shares@ US$147.7322.6% of flowCommon StockSEC:0001214659-22-000419:0
4,045 shares@ US$147.738.1% of flowCommon StockSEC:0001214659-22-000419
7,430 shares0Common StockSEC:0001214659-21-013378
7,430 shares0Common StockSEC:0001214659-21-013378:0
47,204 shares@ US$8.4915.2% of flowCommon StockSEC:0001214659-21-012712:0
47,204 shares@ US$8.495.4% of flowCommon StockSEC:0001214659-21-012712
40,000 shares@ US$8.4912.2% of flowCommon StockSEC:0001214659-21-006762:0
40,000 shares@ US$8.494.3% of flowCommon StockSEC:0001214659-21-006762
23 of 23 declarations
About BAUM CHARLES M
Charles M. Baum is the President, CEO, and Board Member at Mirati Therapeutics, Inc. and Poseida Therapeutics, Inc. He leads these companies with an innovation-focused vision in the biopharmaceutical sector. His leadership is essential for achieving strategic objectives and strengthening the market position of these firms.
